PK5 fundamentals
An in-depth look to BASILEA PHARMACEU operating, investing, and financing activities
PK5 free cash flow for H2 23 is -8.12 M CHF. For 2023, PK5 free cash flow was 13.43 M CHF and operating cash flow was 14.24 M CHF.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM